184 related articles for article (PubMed ID: 35718636)
1. Proteogenomic, Epigenetic, and Clinical Implications of Recurrent Aberrant Splice Variants in Clear Cell Renal Cell Carcinoma.
Chang A; Chakiryan NH; Du D; Stewart PA; Zhang Y; Tian Y; Soupir AC; Bowers K; Fang B; Morganti A; Teer JK; Kim Y; Spiess PE; Chahoud J; Noble JD; Putney RM; Berglund AE; Robinson TJ; Koomen JM; Wang L; Manley BJ
Eur Urol; 2022 Oct; 82(4):354-362. PubMed ID: 35718636
[TBL] [Abstract][Full Text] [Related]
2. Aberrant Epidermal Growth Factor Receptor RNA Splice Products Are Among the Most Frequent Somatic Alterations in Clear Cell Renal Cell Carcinoma and Are Associated with a Poor Response to Immunotherapy.
Zaman S; Hajiran A; Coba GA; Robinson T; Madanayake TW; Segarra DT; Chobrutskiy BI; Boyle TA; Zhou JM; Kim Y; Mulé JJ; Teer JK; Manley BJ
Eur Urol Focus; 2021 Mar; 7(2):373-380. PubMed ID: 31901438
[TBL] [Abstract][Full Text] [Related]
3. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma.
Peng Y; Greenland NY; Lang UE; Stohr BA
Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088
[TBL] [Abstract][Full Text] [Related]
4. HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395.
Sun G; Zhou H; Chen K; Zeng J; Zhang Y; Yan L; Yao W; Hu J; Wang T; Xing J; Xiao K; Wu L; Ye Z; Xu H
J Exp Clin Cancer Res; 2020 Jun; 39(1):116. PubMed ID: 32560659
[TBL] [Abstract][Full Text] [Related]
5. Molecular Characterization of Clear Cell Renal Cell Carcinoma Reveals Prognostic Significance of Epithelial-mesenchymal Transition Gene Expression Signature.
Nallandhighal S; Vince R; Karim R; Groves S; Stangl-Kremser J; Russell C; Hu K; Pham T; Cani AK; Liu CJ; Zaslavsky A; Mehra R; Cieslik M; Morgan TM; Palapattu GS; Udager AM; Salami SS
Eur Urol Oncol; 2022 Feb; 5(1):92-99. PubMed ID: 34840106
[TBL] [Abstract][Full Text] [Related]
6. Integrated multi-omics analyses reveal that BCAM is associated with epigenetic modification and tumor microenvironment subtypes of clear cell renal cell carcinoma.
Zhao J; Liang J; Yang Y; Sun G; Zhang X; Zhao J; Hu X; Chen J; Zhu S; Ni Y; Zhang Y; Dai J; Wang Z; Wang Z; Zeng Y; Yao J; Chen N; Shen P; Liu Z; Zeng H
Clin Epigenetics; 2022 Aug; 14(1):99. PubMed ID: 35941663
[TBL] [Abstract][Full Text] [Related]
7. Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma.
Clark DJ; Dhanasekaran SM; Petralia F; Pan J; Song X; Hu Y; da Veiga Leprevost F; Reva B; Lih TM; Chang HY; Ma W; Huang C; Ricketts CJ; Chen L; Krek A; Li Y; Rykunov D; Li QK; Chen LS; Ozbek U; Vasaikar S; Wu Y; Yoo S; Chowdhury S; Wyczalkowski MA; Ji J; Schnaubelt M; Kong A; Sethuraman S; Avtonomov DM; Ao M; Colaprico A; Cao S; Cho KC; Kalayci S; Ma S; Liu W; Ruggles K; Calinawan A; Gümüş ZH; Geiszler D; Kawaler E; Teo GC; Wen B; Zhang Y; Keegan S; Li K; Chen F; Edwards N; Pierorazio PM; Chen XS; Pavlovich CP; Hakimi AA; Brominski G; Hsieh JJ; Antczak A; Omelchenko T; Lubinski J; Wiznerowicz M; Linehan WM; Kinsinger CR; Thiagarajan M; Boja ES; Mesri M; Hiltke T; Robles AI; Rodriguez H; Qian J; Fenyö D; Zhang B; Ding L; Schadt E; Chinnaiyan AM; Zhang Z; Omenn GS; Cieslik M; Chan DW; Nesvizhskii AI; Wang P; Zhang H;
Cell; 2019 Oct; 179(4):964-983.e31. PubMed ID: 31675502
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-30a-5p
Outeiro-Pinho G; Barros-Silva D; Aznar E; Sousa AI; Vieira-Coimbra M; Oliveira J; Gonçalves CS; Costa BM; Junker K; Henrique R; Jerónimo C
J Exp Clin Cancer Res; 2020 Jun; 39(1):98. PubMed ID: 32487203
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of JAK3 promoter methylation and mRNA expression in clear cell renal cell carcinoma.
Long Q; Huang C; Huang J; Meng Q; Cheng Y; Li Y; He L; Chen M; Zhang C; Wang X; Zhu W; Peng J; Shi D; Zheng F; Dong P; Deng W
J Adv Res; 2022 Sep; 40():153-166. PubMed ID: 36100323
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma.
Zhang C; Huang D; Liu A; Xu Y; Na R; Xu D
J Cell Biochem; 2020 Mar; 121(3):2559-2570. PubMed ID: 31646670
[TBL] [Abstract][Full Text] [Related]
11. Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma.
Manley BJ; Zabor EC; Casuscelli J; Tennenbaum DM; Redzematovic A; Becerra MF; Benfante N; Sato Y; Morikawa T; Kume H; Fukayama M; Homma Y; Ogawa S; Arcila ME; Voss MH; Feldman DR; Coleman JA; Reuter VE; Motzer RJ; Russo P; Hsieh JJ; Hakimi AA
Eur Urol Focus; 2017 Oct; 3(4-5):421-427. PubMed ID: 28753773
[TBL] [Abstract][Full Text] [Related]
12. Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma.
Dong Y; Ma WM; Yang W; Hao L; Zhang SQ; Fang K; Hu CH; Zhang QJ; Shi ZD; Zhang WD; Fan T; Xia T; Han CH
BMC Cancer; 2021 Oct; 21(1):1135. PubMed ID: 34688260
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
14. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X
Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
[TBL] [Abstract][Full Text] [Related]
17. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.
Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW
J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187
[TBL] [Abstract][Full Text] [Related]
18. ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma.
Brooks SA; Brannon AR; Parker JS; Fisher JC; Sen O; Kattan MW; Hakimi AA; Hsieh JJ; Choueiri TK; Tamboli P; Maranchie JK; Hinds P; Miller CR; Nielsen ME; Rathmell WK
Eur Urol; 2014 Jul; 66(1):77-84. PubMed ID: 24613583
[TBL] [Abstract][Full Text] [Related]
19. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.
Zhang S; Xu X; Wang Y; Zhu Y; Wang J; Wang H; Guo J
Ann Clin Lab Sci; 2021 Sep; 51(5):597-608. PubMed ID: 34686501
[TBL] [Abstract][Full Text] [Related]
20. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
